31 results on '"Hoppe, B.S."'
Search Results
2. The Use of Consolidative Proton Therapy After First-Line Therapy Among Patients With Hodgkin Lymphoma at Academic and Community Proton Centers.
3. Patient-Reported Quality of Life and Disease-Specific Outcomes Five Years Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger.
4. Five-Year Outcomes From a Prospective Trial of Image Guided Accelerated Hypofractionated Proton Therapy for Prostate Cancer.
5. Postoperative Proton Therapy for Resected Non-Small Cell Lung Cancer.
6. Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or HIFU.
7. Patient-Reported Hip Symptoms Following Treatment With Proton Therapy for Prostate Cancer.
8. Phase 2 Study of Consolidative Involved-Node Proton Therapy in Patients With Hodgkin Lymphoma: Early Outcomes.
9. Five-Year Outcomes of Proton Therapy in Localized Prostate Cancer on 3 Prospective Trials for Low-, Intermediate-, and High-Risk Prostate Cancer.
10. Pulmonary Toxicity Following Proton Therapy for Patients With Non-Small Cell Lung Cancer.
11. Early Gastrointestinal Toxicity Outcomes From a Prospective Trial of Accelerated Hypofractionation With Proton Therapy for Prostate Cancer.
12. Comparative Effectiveness Study of Proton Therapy Versus IMRT for Definitive Treatment of Prostate Cancer Based on Patient-Reported Outcomes.
13. Ten-Year Outcomes From Three Prospective Clinical Trials Of Image-Guided Proton Therapy In Prostate Cancer.
14. Fact or Fiction: Proton Beam Therapy is Primarily for Patients With Prostate Cancer.
15. Biochemical Outcomes for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy.
16. Seven-Year Outcomes of a Prospective Trial of Concomitant Docetaxel and Proton Therapy for High-Risk Prostate Cancer.
17. Proton Therapy in the Management of High-Risk Prostate Cancer.
18. Identifying Mean Heart Dose Thresholds for Proton Therapy Acceptability in Mediastinal Unfavorable Early-Stage Hodgkin Disease.
19. Five-year Outcomes for Moderately Accelerated Hypofractionated Proton Therapy for Prostate Cancer.
20. Image-Guided Hypofractionated Proton Therapy in the Management of Centrally Located Early-Stage Non-Small Cell Lung Cancer.
21. Potential Improved Outcomes with Proton Therapy in Prostate Cancer: a Comparison of IMRT and Proton Cohorts.
22. Patient-Reported Sexual Survivorship Following Proton Therapy in Prostate Cancer.
23. Knowledge Engineering–Based Quality Evaluation of RTOG 1308 Proton Treatment plans.
24. Proton Therapy for Lymphoma: A Multi-institutional Patterns of Care Study.
25. Impact of Unfavorable Factors on Outcomes Among Inoperable Stage II-IV Non-Small Cell Lung Cancer Patients Treated with Proton Therapy.
26. Changes in Serum Testosterone 60 Months After Proton Therapy for Localized Prostate Cancer.
27. Impact of Unfavorable Factors on Outcomes Among Inoperable Stage II-IV Non-Small Cell Lung Cancer Patients Treated With Proton Therapy.
28. Clinical Outcomes of Patients with Stage II-III Non-Small Cell Lung Cancer (NSCLC) Treated with Proton Beam Therapy (PBT) on the Proton Collaborative Group (PCG) Prospective Registry Trial.
29. Proton Radiation Therapy in Reirradiation for Recurrent NSCLC.
30. Impact on Dose to Abdominal Organs With the Use of Proton Therapy in the Management of Diaphragmatic and Infradiaphragmatic Hodgkin Lymphoma.
31. Grade 3 Genitourinary Toxicities in Men After Proton Therapy for Prostate Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.